


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-14.44%
+22.49%
+0.48%
+12.65%
+2.37%
HALO
Halozyme Therapeutic
$63.33
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Outperform the market
Technical Indicators

5+ Days Down
HALO Price Performance
$68.01 (-6.88%)
$76.9 (-17.65%)
$57.81 (+9.55%)
$47.32 (+33.83%)
HALO has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

HALO overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
HALO Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
HALO Street Sentiment is bullish and have negative views on the near-term outlook
Average key support and resistance price levels
Login to displayWhat is HALO current stock price?
What are HALO stock strengths?
What is HALO Risk Level?
What is HALO market cap and volume?
What is HALO current Stock IQ?
Should I buy HALO stock right now?
Is HALO a Strong Buy right now?
What does a 'Strong Buy' rating mean for HALO?
What does a 'Strong Sell' rating mean for HALO?
What factors influence HALO's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-14.44%
+22.49%
+0.48%
+12.65%
+2.37%
HALO
Halozyme Therapeutic
Current Price
$63.33
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Outperform the market
Technical Indicators

5+ Days Down

HALO Price Performance
$68.01 (-6.88%)
$76.9 (-17.65%)
$57.81 (+9.55%)
$47.32 (+33.83%)
HALO Analysts Opinion
HALO Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
HALO Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
HALO Street Sentiment is bullish and have negative views on the near-term outlook
HALO has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels
HALO Stock IQ
HALO Latest Analysis
Notable Two Hundred Day Moving Average Cross - HALO. In trading on Thursday shares of Halozyme Therapeutics Inc (Symbol: HALO) crossed below their 200 day moving average of $63.07 changing hands as low as $61.70 per share. Halozyme Therapeutics Inc shares are currently trading down about 3% on the day. The chart below shows th
Thu Dec 4, 2025
Halozyme Therapeutics Inc. (HALO) Presents at Evercore 8th Annual Healthcare Conference Transcript.
Tue Dec 2, 2025
What Makes Halozyme Therapeutics (HALO) a New Buy Stock. Halozyme Therapeutics (HALO) might move higher on growing optimism about its earnings prospects which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Mon Dec 1, 2025
Halozyme Therapeutics announces CFO transition agreement with Nicole LaBrosse.
Mon Nov 24, 2025
Merus Licenses ENHANZE Drug Delivery Technology Of Halozyme Therapeutics . (RTTNews) - Monday Merus N.V. (MRUS) has entered into a global non-exclusive collaboration and license agreement regarding Halozyme Therapeutics Inc.s ENHANZE drug delivery technology.
Mon Nov 17, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
HALO Stock trends
HALO Stock performance
HALO Stock analysis
HALO investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.